Comparative Study
. 2002 Jun;34(6):12-6, 20-1; quiz 22-3.
Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer
- PMID: 12090214
Item in Clipboard
Comparative Study
Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer
MLO Med Lab Obs.
2002 Jun.
Abstract
While it is tempting to think of the results of laboratory tests as quantitative, reproducible and accurate, many tests in fact have embedded variables that could lead to inconsistency and sometimes false reporting of results. Tissue-based testing of HER-2/neu in breast cancer represents an example of the latter. This article discusses the available technologies for HER-2/neu testing with some of the sources of testing errors.
Similar articles
-
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Am J Clin Pathol. 2005 Feb;123(2):237-43. Am J Clin Pathol. 2005. PMID: 15842048
-
Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.Breast Cancer Res. 2005;7(2):R256-66. doi: 10.1186/bcr991. Epub 2005 Jan 26. Breast Cancer Res. 2005. PMID: 15743506 Free PMC article.
-
Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.Breast J. 2005 Nov-Dec;11(6):433-9. doi: 10.1111/j.1075-122X.2005.00125.x. Breast J. 2005. PMID: 16297088
-
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.J Cutan Pathol. 2009 Jun;36(6):702-5. doi: 10.1111/j.1600-0560.2008.01114.x. J Cutan Pathol. 2009. PMID: 19515052 Review.
-
[Guidelines on genetic research and genetic testing].Nihon Rinsho. 2010 Aug;68 Suppl 8:280-7. Nihon Rinsho. 2010. PMID: 20979283 Review. Japanese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous